Prestige Consumer Healthcare Inc
F:PBV
Wall Street
Price Targets
PBV Price Targets Summary
Prestige Consumer Healthcare Inc
According to Wall Street analysts, the average 1-year price target for
PBV
is 63.2 EUR
with a low forecast of 53.99 EUR and a high forecast of 74.83 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PBV's stock price target?
Price Target
63.2
EUR
According to Wall Street analysts, the average 1-year price target for
PBV
is 63.2 EUR
with a low forecast of 53.99 EUR and a high forecast of 74.83 EUR.
What is Prestige Consumer Healthcare Inc's Revenue forecast?
Projected CAGR
1%
For the last 13 years the
compound annual growth rate for
Prestige Consumer Healthcare Inc's revenue is
8%.
The projected
CAGR
for the next 3 years is
1%.
What is Prestige Consumer Healthcare Inc's Operating Income forecast?
Projected CAGR
0%
For the last 13 years the
compound annual growth rate for
Prestige Consumer Healthcare Inc's operating income is
10%.
The projected
CAGR
for the next 3 years is
0%.
What is Prestige Consumer Healthcare Inc's Net Income forecast?
Projected CAGR
4%
For the last 13 years the
compound annual growth rate for
Prestige Consumer Healthcare Inc's net income is
14%.
The projected
CAGR
for the next 3 years is
4%.
